government initiatives in veterinary services is driving the Preclinical Animal Imaging Market
Technavio analyzes that the Preclinical Animal Imaging Market is expected to grow at a CAGR of 5.3% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1169.8 million.There are various factors that contribute to the growth of the market. The Preclinical Animal Imaging Market has witnessed significant growth due in part to government initiatives aimed at advancing veterinary services. These initiatives include funding for research and development of new imaging technologies, as well as regulations that encourage the use of non-invasive imaging techniques in veterinary medicine. This trend is expected to continue, as governments worldwide recognize the importance of improving animal health and welfare through innovative diagnostic tools. The integration of advanced imaging technologies in veterinary services will lead to earlier and more accurate diagnoses, ultimately benefiting both animals and their owners.
The preclinical animal imaging market is divided into segments based on technology, with imaging instruments playing a pivotal role in enhancing research capabilities. The IVIS SpectrumCT from Perkin Elmer Inc. is a prime example of advanced imaging systems. This versatile instrument integrates optical and microCT technologies, enabling researchers to conduct comprehensive longitudinal studies on small animal models. The IVIS SpectrumCT facilitates simultaneous molecular and anatomical imaging, providing valuable insights into intricate biological systems. Its horizontal gantry motion and flat panel detector ensure exceptional low-dose imaging performance. Furthermore, the automated integration of optical and microCT imaging streamlines the research process. Utilizing receptor-binding radiotracers and radiopharmaceuticals in in vitro and in vivo studies, this system combines the optical capabilities of the IVIS and Maestro platforms with microCT technology, offering a powerful tool for preclinical research.
Know which region is leading the market growth by requesting a sample report
Preclinical Animal Imaging Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The preclinical animal imaging market encompasses the development and application of advanced imaging technologies for translational research in the field of oncology. This involves the use of targeted anticancer agents, such as radiolabeled probes, to identify sensitive and resistant tumors. Molecular and genetic tests, including imaging biomarkers, are utilized to assess oncogene drivers and drug resistance. Techniques like autoradiography, receptor-binding radiotracers, and radiopharmaceuticals are employed in in vitro and in vivo studies using non-human primates and various animal models. Kinetic, saturation, and competition binding studies are conducted to evaluate specific binding and optimize imaging methods. Brain imaging, using techniques like dopamine transporter (DAT) scans and behavioral studies, is another important application. Novel functional imaging methods and state-of-the-art infrastructure continue to drive innovation in this field.
The Preclinical Animal Imaging Market is a significant segment of the global healthcare equipment industry, which encompasses companies and products involved in the research and development (R&D) of diagnostic equipment and devices for the detection and treatment of various diseases. Technavio, a leading technology research and consulting firm, categorizes this market within the larger healthcare equipment sector, which generates revenue from manufacturers of capital equipment, instruments, implants, accessories, and consumables. The Preclinical Animal Imaging Market specifically focuses on translational processes, such as the development of targeted anticancer agents, and clinical applications, including radiolabeled probes for identifying oncogene drivers and sensitive tumors. These advancements contribute to the growth of the market, which is expected to experience significant expansion in the coming years.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/